Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Role of silymarin as antioxidant in clinical management of chronic liver diseases: a narrative review.

Autor: Aghemo A; Department of Biomedical Sciences, Humanitas Research Hospital IRCCS, Sosnowiec, Poland., Alekseeva OP; Gastroenterological Center, Semashko National Research University, Moscow, Russia., Angelico F; Sapienza School of Medicine, Rome, Italy., Bakulin IG; Department of Propaedeutics of Internal Diseases, Federal State Medical University of Ministry of Health of Russia, Chief Specialist-Therapist of the North-Western Federal district, Moscow, Russia., Bakulina NV; Department of Therapy and Clinical Pharmacology, North-Western State Medical University, Moscow, Russia., Bordin D; Department of Pancreatic, Biliary, and Upper Digestive Tract Disorders, A.S. Loginov Moscow Clinical Scientific Center, Moscow, Russia., Bueverov AO; Department of Gastroenterology and Hepatology, Moscow Medical Academy, Moscow, Russia., Drapkina OM; Ministry of Health of the Russian Federation, Chief Specialist of Therapy and General Practice Ministry of Health of Russia, Grozny, Russia., Gillessen A; Department of Internal Medicine, Herz-Jesu-Hospital, Muenster, Germany., Kagarmanova EM; Gastroenterological Department, GBUZ RB City clinical Hospital, Sterlitamak, Russia., Korochanskaya NV; Gastroenterology Center, Regional Clinical Hospital, Tyumen, Russia., Kucheryavii UA; Department of Propaedeutics of Internal Diseases and Gastroenterology, Moscow State University of Medicine and Dentistry, Moscow, Russia., Lazebnik LB; Department of Polyclinic Therapy, Moscow State University of Medicine and Dentistry, Moscow, Russia., Livzan MA; Department of Faculty Therapy, Omsk State Medical University, Omsk, Russia., Maev IV; Department of Propedeutics of Internal Diseases and Gastroenterology, Moscow State University of Medicine and Dentistry, Moscow, Russia., Martynov AI; Department of Internal Diseases, Moscow State University of Medicine and Dentistry, Moscow, Russia., Osipenko MF; Department for Science, Innovations and Informatization, Novosibirsk State Medical University, Novosibirsk, Russia., Sas EI; 2nd Department of Therapy, Ministry of Defense of the Russian Federation, Moscow, Russia., Starodubova A; Department of Scientific and Clinical Work, INSTITUTE 'Federal Research Center of Nutrition and Biotechnologies', Moscow, Russia., Uspensky YP; Department of faculty therapy, Saint Petersburg State Pediatric Medical University (Spbpgmu) of the RF MOH, St. Petersburg, Russia., Vinnitskaya EV; Department of Hepatology, Moscow Clinical Research and Practice Center, Moscow, Russia., Yakovenko EP; Department of Gastroenterology, Faculty of Advanced Medical Education of the Russian National Research Medical University, Moscow, Russia., Yakovlev AA; Department of gastroenterology and endoscopy, Rostov State Medical, Rostov, Russia.

Publikováno v: Annals of medicine [Ann Med] 2022 Dec; Vol. 54 (1), pp. 1548-1560.

Randomised clinical trial: otilonium bromide improves frequency of abdominal pain, severity of distention and time to relapse in patients with irritable bowel syndrome.

Autor: Clavé P; Department of Surgery, Hospital de Mataró, Universitat Autònoma de Barcelona, Barcelona, Spain., Acalovschi M, Triantafillidis JK, Uspensky YP, Kalayci C, Shee V, Tack J

Publikováno v: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2011 Aug; Vol. 34 (4), pp. 432-42. Date of Electronic Publication: 2011 Jun 16.